Try our mobile app

Neurocrine Biosciences Presents Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease at AAN 2022

Published: 2022-04-01 12:30:00 ET
<<<  go to NBIX company page

ValbenazineMet the Primary Endpoint of Significant (p